BNP Paribas Financial Markets Makes New $108,000 Investment in Zymeworks Inc. (NYSE:ZYME)
BNP Paribas Financial Markets acquired a new position in shares of Zymeworks Inc. (NYSE:ZYME – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 7,363 shares of the company’s stock, valued at approximately $108,000. Other hedge funds also recently added to or reduced their stakes in […]
